Jun Bao

Jun Bao

Chairman at
BiTech Pharma, Inc.
59 year
Health Technology
Consumer Services
Commercial Services

Profile

Jun Bao is currently Chairman at BiTech Pharma, Inc. and Chief Business Officer at Biotheus, Inc. since 2022.
Former roles include President & Chief Executive Officer at IMPACT Therapeutics, Inc. from 2018 to 2022, Independent Non-Executive Director at Transcenta Holding Ltd. from 2021 to 2023, Director at Beijing Shenogen Pharma Group Ltd. from 2018 to 2019, Director-Worldwide Business Development at Glaxosmithkline China Ltd. from 2010 to 2013, Director-Development & Financial Planning at Onyx Pharmaceuticals, Inc., Senior Manager-Business Development at CTI BioPharma Corp.
from 2001 to 2005, Associates Director-Business Development at ICOS Corp.
from 2005 to 2006, and Finance Manager at Procter & Gamble Co. from 1999 to 2001.
Education includes an MBA from The University of Chicago in 1999, a doctorate from the University of Kansas in 1994, and an undergraduate degree from Shandong University in 1986.

Jun Bao active positions

CompaniesPositionStart
Chairman 03/07/2009
Corporate Officer/Principal 01/10/2022

Former positions of Jun Bao

CompaniesPositionEnd
TRANSCENTA HOLDING LIMITED Director/Board Member 23/08/2023
IMPACT THERAPEUTICS, INC Chief Executive Officer 01/09/2022
Director/Board Member 01/10/2019
Glaxosmithkline China Ltd.
Corporate Officer/Principal 01/05/2013
Corporate Officer/Principal 01/01/2006
See the detail of Jun Bao's experience

Training of Jun Bao

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

95

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Consumer Non-Durables

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Consumer Services

Glaxosmithkline China Ltd.

Health Technology

Health Technology

Commercial Services

Health Technology